EFTA01522103.pdf

GH1SLAINE MAXWELL- OAP FDG ACCT. For the Period 11/1/11 to 1150/I I Equity Summary Beginning Ending Change Current Asset Categories Asset Categories Market Value Market Value In Value Allocation US Large Cap Equity 156.591.73 149.086 00 (7,505.73) 93% Concentrated & Other Equity 0.00 6.135 36 6.135.36 4% i Total Value $156,591.73 $155,221.36 ($1.370.37) 97% Concentrated S Other Equity Current Market Value/Cost Period Value Market Value 155221.36 Tax Cost 146,020.49 Unrealized Gain,Loss 9,200.87 US Large Cap Equity Estimated Annual Income 5,388.03 Accrued Divdends 788.09 Yield 3.47% Equity as a percentage of your portfolio 97 % Note: P indicates position adjusted for Pending Trade Activity. Equity Detail Adjusted Tax Cost Unrealized Est. Annual Inc. Price Gummy Value Original Cost Gain/Loss Accrued Div. Yield US Large Cap Equity ABBOTT LABORATORIES 54.55 146.000 8,073.40 7,30874 784.66 284.16 3.52% 002824-10-OAST P AIR PRODUCTS & CHEMICALS INC 83.75 0.00 2.77% 009158-10-6 APO J.P. Morgan Page 4 of 12 Confidential Treatment Requested by JPMorgan JPM-SDNY-00049583 Chase CONFIDENTIAL SDNY_GM_00318781 EFTA01522103